ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Enveric Biosciences Inc

Enveric Biosciences Inc (ENVB)

0.51
0.00
(0.00%)
Closed July 09 4:00PM
0.5195
0.0095
(1.86%)
After Hours: 7:24PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.5195
Bid
0.49
Ask
0.519
Volume
180,120
0.4917 Day's Range 0.5199
0.49 52 Week Range 3.8978
Market Cap
Previous Close
0.51
Open
0.5134
Last Trade
5
@
0.5198
Last Trade Time
Financial Volume
$ 91,230
VWAP
0.506497
Average Volume (3m)
503,544
Shares Outstanding
7,752,005
Dividend Yield
-
PE Ratio
-0.23
Earnings Per Share (EPS)
-2.25
Revenue
-
Net Profit
-17.46M

About Enveric Biosciences Inc

Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline include... Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline includes Glioblastoma Multiforme (GBM); Radiation Dermatitis and Chemotherapy-Induced Peripheral Neuropathy (CIPN). Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Enveric Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ENVB. The last closing price for Enveric Biosciences was $0.51. Over the last year, Enveric Biosciences shares have traded in a share price range of $ 0.49 to $ 3.8978.

Enveric Biosciences currently has 7,752,005 shares outstanding. The market capitalization of Enveric Biosciences is $3.95 million. Enveric Biosciences has a price to earnings ratio (PE ratio) of -0.23.

ENVB Latest News

Enveric Biosciences Provides Strategic Outlook and Pipeline Update, Elevating EB-003 to Lead Development Candidate

EB-003 is a novel, neuroplastogenic molecule designed to treat severe mental health disorders without the hallucinogenic effect typically associated with psychedelic-based compounds Enveric is...

Enveric Biosciences to Participate in BIO International Convention 2024

Enveric Biosciences (NASDAQ: ENVB) (β€œEnveric” or the β€œCompany”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of...

Enveric Biosciences Reports First Quarter 2024 Financial and Corporate Results

Revealed seven classes of promising novel drug candidates discovered using Enveric’s Psybraryβ„’ and PsyAIβ„’ drug discovery and artificial intelligence (AI) platforms Launched business development...

Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders

MindBio to develop the novel psilocin prodrug for neuropsychiatric indications utilizing microdosing to reduce or eliminate hallucinogenic impact of psychedelic compounds Enveric Biosciences...

Enveric Biosciences Announces Signing of Non-Binding Term Sheet with Undisclosed Licensee for Exclusive License to Patented Methods of Treating Breast and Other Cancers Using Cannabinoids

Biotechnology licensee expected to progress methods targeting breast and other cancers using cannabinoids in combination with chemotherapeutic drugs Enveric Biosciences, Inc (NASDAQ: ENVB), a...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.1067-17.03928457360.62620.63950.491599950.53565587CS
4-0.2406-31.65372977240.76010.7880.491069370.62579722CS
12-0.5005-49.0686274511.021.030.495035440.92766706CS
26-0.7505-59.0944881891.272.920.4924459641.3233092CS
52-2.5605-83.13311688313.083.89780.4912499961.35005592CS
156-1.5505-74.90338164252.0714.870.155116111651.95192813CS
260-5.2805-91.04310344835.814.870.155119862862.5808377CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SHPWShapeways Holdings Inc
$ 0.5041
(140.05%)
92.14M
ZAPPZapp Electric Vehicles Group Ltd
$ 9.25
(127.27%)
105.05M
IVPInspire Veterinary Partners Inc
$ 2.94
(97.32%)
54.79M
VRPXVirpax Pharmaceuticals Inc
$ 1.10
(90.31%)
161.22M
MORFMorphic Holding Inc
$ 55.71
(74.97%)
53.24M
HLVXHilleVax Inc
$ 1.63
(-88.41%)
25.64M
CLEUChina Liberal Education Holdings Ltd
$ 0.568999
(-73.90%)
15.69M
SYTSYLA Technologies Company Ltd
$ 2.07
(-31.91%)
534.24k
CJETChijet Motor Company Inc
$ 6.00
(-25.93%)
188.91k
WETHWetouch Technology Inc
$ 2.44
(-22.78%)
518.66k
MAXNMaxeon Solar Technologies Ltd
$ 0.2722
(13.42%)
493.51M
NVDANVIDIA Corporation
$ 128.20
(1.88%)
237.67M
VRPXVirpax Pharmaceuticals Inc
$ 1.10
(90.31%)
161.22M
TSLATesla Inc
$ 252.94
(0.56%)
157.27M
SVMHSRIVARU Holding Ltd
$ 0.1874
(17.94%)
121.48M

ENVB Discussion

View Posts
Monksdream Monksdream 1 week ago
ENVB new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 2 months ago
Mighty fluffy press release
πŸ‘οΈ0
Awl416 Awl416 2 months ago
Enveric Biosciences Announces Signing of Non-Binding Term Sheet with Undisclosed Licensee for Exclusive License to Patented Methods of Treating Breast and Other Cancers Using Cannabinoids
πŸ‘οΈ0
Awl416 Awl416 4 months ago
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
ENVB under $2
πŸ‘οΈ0
glenn1919 glenn1919 4 months ago
ENVB.........................................https://stockcharts.com/h-sc/ui?s=ENVB&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Invest-in-America Invest-in-America 4 months ago
ENVB: The Pro's are now workin' on their THIRD-NICE-FLIP behind this (easy money) puppy today!!! (I.e., one 100%-profit flip in the Pre-M, & now TWO circa 25-to-30%-profit flips in the Open-M!!! Yet STUPID traders cry about "Wash Trades". L.M.M.F.A.O.!!!!!)
πŸ‘οΈ0
Invest-in-America Invest-in-America 4 months ago
ENVB: Heck, "Wash-Trades" keep those PROFITS nice & CLEAN!!!!
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
Wash trade du jour
πŸ‘οΈ0
Invest-in-America Invest-in-America 4 months ago
ENVB: I'm buyin' latte's for everyone later today, up on the MOON!!!
πŸ‘οΈ0
Invest-in-America Invest-in-America 4 months ago
ENVB: 3-bagger from here, whether anybody likes it or not!! (Just the way it goes, these days!!)
πŸ‘οΈ0
TimeFades TimeFades 4 months ago
Nasty trap
πŸ‘οΈ0
TimeFades TimeFades 4 months ago
Short
πŸ‘οΈ0
tw0122 tw0122 4 months ago
The term sheets further provide that, Enveric could be eligible to receive future development and sales milestone payments and execution fees for the three licenses, which in total could add up to $200 million, assuming certain conditions are met, including receiving approval for the investigational new drug (IND) applications and completing Phases I through III testing of the licensed products. Royalty rates on each of the three licenses could range from 2.5% up to 10% on future sales, depending on meeting certain sales criteria. The compound classes under the term sheets come from two of the seven portfolios of preclinical molecules that Enveric recently unveiled as available for out-licensing. Numerous molecules and classes remain available for additional out-licensing opportunities.

β€œPatients living with serious mental health conditions have seen insufficient innovation for far too long, and we are excited for the opportunity to progress several of the novel compounds generated using our drug discovery engine,” said Joseph Tucker, Ph.D., Director and CEO of Enveric. β€œWe look forward to working with our partner, and we are confident in their leadership and capabilities to work on further developing these drug candidates to advance treatment options for patients. Ultimately, we believe the definitive licensing agreements, once negotiated and finalized, could represent an excellent potential source of revenue for Enveric, and could demonstrate the value creation from Enveric’s discovery capabilities and proprietary PsyAI™ and Psybrary™ platforms, which have already generated an impressive library of compounds targeting a variety of CNS disorders.”
πŸ‘οΈ0
glenn1919 glenn1919 4 months ago
ENVB.........................................https://stockcharts.com/h-sc/ui?s=ENVB&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Awl416 Awl416 4 months ago
Enveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual Property
πŸ‘οΈ0
I-Glow I-Glow 10 months ago
What's the patent application number?

IG
πŸ‘οΈ0
Awl416 Awl416 11 months ago
4.96 to 3 blink of any eye
πŸ‘οΈ0
Triple nickle Triple nickle 1 year ago
7.52 easy
πŸ‘οΈ0
Jess070283 Jess070283 1 year ago
$4-$5.75. Done for the day. Wooo
πŸ‘οΈ0
Awl416 Awl416 1 year ago
Enveric Biosciences Receives Notice of Allowance From USPTO for C4-Carboxylic Acid-Substituted Tryptamine Derivatives for Next Generation Psilocin Prodrug
πŸ‘οΈ0
PennyPusher786 PennyPusher786 1 year ago
Nice flipper
πŸ‘οΈ0
Triple nickle Triple nickle 1 year ago
Ok it cooled off
Five dollar run
πŸ‘οΈ0
PennyPusher786 PennyPusher786 1 year ago
Now a Rug Pooool candidate lol... Now it's too dangerous... It can run 4+ but it can dump too as seen from 4.20s to 3.20s in all of 15 seconds
πŸ‘οΈ0
PennyPusher786 PennyPusher786 1 year ago
Another rip or another dump, only the devil knows
πŸ‘οΈ0
PennyPusher786 PennyPusher786 1 year ago
Good call. Ran to 4.20s and dumped to 3.20s
πŸ‘οΈ0
Triple nickle Triple nickle 1 year ago
I’m out
πŸ‘οΈ0
surf1944 surf1944 1 year ago
https://stockcharts.com/h-sc/ui?s=envb&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/envb/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100

https://www.barchart.com/stocks/quotes/envb/opinion

Open gap at $1.52
πŸ‘οΈ0
PennyPusher786 PennyPusher786 1 year ago
There's another pullback
πŸ‘οΈ0
Invest-in-America Invest-in-America 1 year ago
Ooooooops!! (iHub posting error, glitch, etc.).
πŸ‘οΈ0
Invest-in-America Invest-in-America 1 year ago
ENVB: I'm workin' on an ANSWER to your question right now, Sir. (See my 'Chart' on this, below.)

πŸ‘οΈ0
TheFinalCD TheFinalCD 1 year ago
WALL @ 3.50 JUST TAKEN OUT
πŸ‘οΈ0
PennyPusher786 PennyPusher786 1 year ago
Anyone smell a bait and pull? Lol or do we forsee $5- 6
πŸ‘οΈ0
Invest-in-America Invest-in-America 1 year ago
ENVB: See ya-all up on the MOON later, Folks!!
πŸ‘οΈ0
PennyPusher786 PennyPusher786 1 year ago
Same. I expect pullbacks and runs if the volume stays consistent.. which means mass flipping
πŸ‘οΈ0
Triple nickle Triple nickle 1 year ago
Watching
πŸ‘οΈ0
PennyPusher786 PennyPusher786 1 year ago
This could run 5 - 6 today.
πŸ‘οΈ0
Triple nickle Triple nickle 1 year ago
Sell down now
πŸ‘οΈ0
Awl416 Awl416 1 year ago
Enveric Biosciences Receives Notice of Allowance from USPTO for Novel Prodrug of Psilocin
πŸ‘οΈ0
DDA DDA 2 years ago
The RS already took place. Don't understand why my post would need to ve deleted
πŸ‘οΈ0
Klinsmann Klinsmann 2 years ago
But gonna be a nice entry soon imo
πŸ‘οΈ0
Roadtojourney Roadtojourney 2 years ago
Rs and dilution followed right after wow??
πŸ‘οΈ0
DDA DDA 2 years ago
Reverse split just anounced
πŸ‘οΈ0
BoilerRoom BoilerRoom 2 years ago
What are other biotech stocks I’m not familiar with this sector. Appreciate your feedback MASTERULTRA you seem to know about these.
πŸ‘οΈ0
MASTERULTRA MASTERULTRA 2 years ago
Seriously, WTF!!! this company should be trending higher due to 04/20...

I fucking hope the people who short this or manipulate this gets Karma.
πŸ‘οΈ0
DallasInvest DallasInvest 2 years ago
The douche canoe Dj front load of the day lol
πŸ‘οΈ0
TommyBoyTrader9460 TommyBoyTrader9460 2 years ago
$ENVB Added..looks like interest building here..
πŸ‘οΈ0
kzivann kzivann 2 years ago
Back on watch .. Bottom or how much lower?

ENVB
πŸ‘οΈ0
The ELTP King The ELTP King 2 years ago
Agreed.

This company is a total loser with zero revenue.

Absolute embarrassment.

New CFO Carter Ward ran this company into the ground in just 9 months.

Delist imminent or reverse split.





πŸ‘οΈ0
NASDAQ2020 NASDAQ2020 3 years ago
Delist imminent or reverse split.
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock